Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
K KonstantopoulosT Doskas

Abstract

The Montreal Cognitive Assessment (MoCA) is a brief cognitive instrument for the measurement of dementia. The aim of the present study is to provide normative data for the MoCA test in the Greek speaking population and to measure its validity in a clinical group of parkinsonian dementia participants. A total of 710 healthy Greek speaking participants and 19 parkinsonian dementia participants took part in the study. Both, the MoCA test and a neuropsychological test battery (digit span, semantic verbal fluency, phonemic verbal fluency, Color Trails Test) were administered to the normative and clinical samples. The test was found to correlate with all neuropsychological tests used in the test battery and it showed high discriminant validity (optimal screening cutoff point = 21, sensitivity = 0.82, specificity = 0.90) in the parkinsonian dementia participants. Further research is needed to use it in larger clinical samples and in different neurological diseases.

References

Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Mar 12, 2004·Journal of the International Neuropsychological Society : JINS·Mary H KosmidisGrigorios Kiosseoglou
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Apr 7, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·John N CavinessCharles H Adler
May 31, 2007·Brain : a Journal of Neurology·C H Williams-GrayR A Barker
Jun 2, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Murat EmreBruno Dubois
Nov 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Cindy ZadikoffConnie Marras
Sep 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Kelvin L ChouUNKNOWN Parkinson Study Group Cognitive/Psychiatric Working Group
Nov 10, 2010·Neurology·J C Dalrymple-AlfordT J Anderson
Nov 16, 2011·Journal of Clinical and Experimental Neuropsychology·Sandra FreitasIsabel Santana
Feb 7, 2012·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Masafumi IharaRyosuke Takahashi
Feb 5, 2013·Applied Neuropsychology. Adult·Kostas KonstantopoulosKonstantinos Spengos
May 17, 2013·Journal of the American Geriatrics Society·Rose Anne KennyGeorge M Savva
Apr 2, 2014·International Psychogeriatrics·Latha VelayudhanGill Livingston
Jul 22, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S HorstmannR Veltkamp
Jul 26, 2014·Journal of Alzheimer's Disease : JAD·Noga OrenYulia Lerner
Aug 21, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Silvia ContiMirco Vanelli Coralli
Sep 2, 2014·Parkinsonism & Related Disorders·Nagaendran KandiahLouis Cs Tan
Sep 6, 2014·Stroke; a Journal of Cerebral Circulation·Rosalind LeesTerence J Quinn
Nov 9, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Gabriella SantangeloLuigi Trojano

❮ Previous
Next ❯

Citations

Sep 14, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Constantinos KormasConstantin Potagas
Jul 8, 2020·Applied Neuropsychology. Adult·Constantinos KormasConstantin Potagas
Jul 16, 2020·Clinical Linguistics & Phonetics·Christos PapatzalasIlias Papathanasiou
Jan 28, 2020·Ear and Hearing·Gabrielle H SaundersDoris-Eva Bamiou
Oct 2, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Hirotaka IwakiMike A Nalls
Mar 10, 2017·The Clinical Neuropsychologist·Fadi Abou-MradPatricia Fadel
Mar 27, 2019·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Harisd PhannarusWattanachai Chotinaiwattarakul
Jun 28, 2018·Journal of Alzheimer's Disease : JAD·Alessandra E ThomannAndreas U Monsch
Apr 4, 2019·Applied Neuropsychology. Adult·Kostas Konstantopoulos, Paris Vogazianos
Aug 10, 2019·Frontiers in Aging Neuroscience·Constantinos KormasConstantin Potagas
Jul 13, 2017·Journal of Alzheimer's Disease : JAD·Emma BorlandSebastian Palmqvist
Dec 31, 2019·Applied Neuropsychology. Adult·Anastasia NousiaEfthimios Dardiotis
Sep 11, 2019·Journal of Geriatric Psychiatry and Neurology·Odelia ElkanaElissa L Ash
Jul 27, 2021·Movement Disorders Clinical Practice·Marta StatuckaMelanie Cohn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.